SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial (Q57591310)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 November 2013

Language	Label	Description	Also known as
English	SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial	scientific article published on 01 November 2013

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

phase II clinical trial

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Hitoshi Onouchi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Hiroki Sano

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Nobuo Funao

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Shingo Kuroda

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Kohei Kaku

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

1 November 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

The Lancet: Diabetes & Endocrinology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

125-132

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Treatment adherence in chronic disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes and adherence to medications measured by claims data in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review of adherence with medications for diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of diabetes treatment adherence and the association with clinical and economic outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A summary of the ADVANCE Trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sitagliptin phosphate: a DPP-4 inhibitor for the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970149-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-8587(13)70149-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622716%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57591310&oldid=2146183868"